Home › Urothelial (Transitional Cell) Carcinoma › Michigan › Ann Arbor

Urothelial (Transitional Cell) Carcinoma clinical trials in Ann Arbor, MI

6 studies for Urothelial (Transitional Cell) Carcinoma are looking for participants at sites in and around Ann Arbor (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer

RecruitingPhase 3

Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi away
Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 15 mi away
Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · 18 mi away

Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06524544

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

RecruitingPhase 2

Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
Huron Gastroenterology PC, Ypsilanti · 7 mi away
Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi away
and 4 more

Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT03866382